U.S. flag

An official website of the United States government

NM_000448.3(RAG1):c.256_257del (p.Lys86fs) AND Recombinase activating gene 1 deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 14, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003401250.1

Allele description [Variation Report for NM_000448.3(RAG1):c.256_257del (p.Lys86fs)]

NM_000448.3(RAG1):c.256_257del (p.Lys86fs)

Gene:
RAG1:recombination activating 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
11p12
Genomic location:
Preferred name:
NM_000448.3(RAG1):c.256_257del (p.Lys86fs)
Other names:
NM_000448.3(RAG1):c.256_257del; p.Lys86fs
HGVS:
  • NC_000011.10:g.36573560_36573561del
  • NG_007528.1:g.10548_10549del
  • NM_000448.3:c.256_257delMANE SELECT
  • NM_001377277.1:c.256_257del
  • NM_001377278.1:c.256_257del
  • NM_001377279.1:c.256_257del
  • NM_001377280.1:c.256_257del
  • NP_000439.2:p.Lys86fs
  • NP_001364206.1:p.Lys86fs
  • NP_001364207.1:p.Lys86fs
  • NP_001364208.1:p.Lys86fs
  • NP_001364209.1:p.Lys86fs
  • LRG_98:g.10548_10549del
  • NC_000011.9:g.36595110_36595111del
  • NM_000448.2:c.256_257delAA
  • NM_000448.3:c.256_257del
Links:
OMIM: 179615.0013; dbSNP: rs772962160
NCBI 1000 Genomes Browser:
rs772962160
Molecular consequence:
  • NM_000448.3:c.256_257del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001377277.1:c.256_257del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001377278.1:c.256_257del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001377279.1:c.256_257del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001377280.1:c.256_257del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Recombinase activating gene 1 deficiency
Identifiers:
MONDO: MONDO:0000572; MedGen: CN375631

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004102807ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen SCID ACMG Specifications RAG1 V1.0.0)
Pathogenic
(Nov 14, 2023)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen, SCV004102807.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.256_257del (p.Lys86ValfsTer33) variant in RAG1 is a frameshift variant that may cause a premature stop codon that is predicted to escape nonsense-mediated decay. The variant causes a truncation of a functionally important region (removes amino acids 86-1011) of the RAG1 protein. The variants also cause the usage of an alternative in-frame start codon (Met183), but the alternatively transcribed protein has decreased recombination activity and mislocalization in cells (PMIDs 11121059, 27301863). So the variant may cause protein loss-of-function (PVS1; PMIDs 11121059, 27301863). The filtering allele frequency based on the European (non-Finnish) population (upper bound of 95% CI of 6/128846 observed alleles) is 0.000007030 in gnomAD v2.1.1 which is below the SCID-VCEP threshold (<0.000102) and therefore meets this criterion (PM2_Supporting). The in vitro recombination assay shows that the p.Lys86ValfsTer33 variant in RAG1 causes a decrease of recombination activity to below 25%, indicating that the variant impacts the protein function. (PS3_Moderate; PMID 24290284). One homozygous individual with OS. One homozygous individual with SCID. 1pt for PM3. (PMID 11121059, patient OS8; PMID 32655540, patient #32). PM3 met. One patient with this variant was diagnosed with SCID (0.5pt). The patient showed T-B-NK+ lymphocyte profile (0.5pt). 1pt in total, PP4 met. (PMID 32655540, proband #32) In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PVS1, PM2_supporting, PM3_moderate, PS3_moderate, and PP4_supporting. (VCEP specifications version 1).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024